What you posted is INCORRECT. The AstraZeneca table in your own post states specifically that data will be available >2023 (in 2024 at the earliest).
So your statement ”You will also notice that data is anticipated to be released in 2023 for both trials” is just WRONG.
Latest quarterly update on AZD0466 today, page-13
Add SPL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
9.7¢ |
Change
-0.003(3.00%) |
Mkt cap ! $40.90M | |||
| Open | High | Low | Value | Volume |
| 10.0¢ | 10.0¢ | 9.7¢ | $37.78K | 385.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 23802 | 9.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 9.8¢ | 39556 | 3 |
View Market Depth
| Last trade - 15.04pm 03/10/2024 (20 minute delay) ? |
| SPL (ASX) Chart |